HLS Therapeutics Inc (TSE:HLS)

HLS Therapeutics Inc (HLS) Financial Statements


HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-1.049; its P/E ratio is -4.10; and it has a dividend yield of 4.65%. HLS Therapeutics Inc is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is C$-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 14.76M$ 15.68M$ 15.53M$ 14.56M$ 15.69M
Gross Profit$ 13.31M$ 14.16M$ 14.38M$ 13.60M$ 14.57M
EBIT$ -3.94M$ -4.60M$ -7.41M$ -1.75M$ -1.73M
EBITDA--$ 1.08M$ 6.64M$ 6.32M
Net Income Common Stockholders$ -5.79M$ -6.43M$ -9.14M$ -3.62M$ -4.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.21M$ 20.72M$ 21.16M$ 22.66M$ 21.18M
Total Assets$ 234.16M$ 241.65M$ 266.63M$ 270.52M$ 275.90M
Total Debt$ 95.20M$ 100.05M$ 91.63M$ 94.63M$ 97.57M
Net Debt$ 73.98M$ 79.33M$ 70.47M$ 71.97M$ 76.39M
Total Liabilities$ 115.26M$ 116.33M$ 122.23M$ 111.50M$ 115.17M
Stockholders Equity$ 118.89M$ 125.32M$ 144.40M$ 159.03M$ 160.74M
Cash Flow-
Free Cash Flow$ 4.02M$ 3.50M$ 3.43M$ 5.72M$ 3.56M
Operating Cash Flow$ 4.02M$ 3.52M$ 3.51M$ 5.76M$ 3.98M
Investing Cash Flow-$ -20.00K$ -81.00K$ -35.00K$ -422.00K
Financing Cash Flow$ -3.51M$ -4.09M$ -4.80M$ -4.30M$ -4.17M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis